Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study.

[1]  F. Maltais,et al.  The major limitation to exercise performance in COPD is lower limb muscle dysfunction. , 2008, Journal of applied physiology.

[2]  G. Hasenfuss,et al.  Slow breathing reduces sympathoexcitation in COPD , 2008, European Respiratory Journal.

[3]  W. E. Langbein,et al.  Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? , 2008, American journal of respiratory and critical care medicine.

[4]  M. Pistolesi,et al.  Outcomes for COPD pharmacological trials: from lung function to biomarkers , 2008, European Respiratory Journal.

[5]  P. Dandona,et al.  Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade , 2007, Journal of Human Hypertension.

[6]  M. Meysman.  Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial , 2006, European Respiratory Journal.

[7]  S. Anker,et al.  Neurohumoral activation as a link to systemic manifestations of chronic lung disease. , 2005, Chest.

[8]  R. Casaburi,et al.  Exercise Training Decreases Ventilatory Requirements and Exercise-Induced Hyperinflation at Submaximal Intensities in Patients With COPD , 2005 .

[9]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[10]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[11]  A. Brown,et al.  Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia , 2003, European Respiratory Journal.

[12]  M. Guazzi,et al.  Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity. , 2003, Journal of the American College of Cardiology.

[13]  M. Hoeper,et al.  Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids , 2003, European Respiratory Journal.

[14]  K. Hirata,et al.  Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study , 2003, Thorax.

[15]  K. Hirata,et al.  Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. , 2002, Chest.

[16]  G. Hasenfuss,et al.  Marked sympathetic activation in patients with chronic respiratory failure. , 2001, American journal of respiratory and critical care medicine.

[17]  K. Hirata,et al.  Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[18]  M. Tsukino,et al.  The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. , 2000, American journal of respiratory and critical care medicine.

[19]  G. Pontone,et al.  Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure. , 1999, The American journal of cardiology.

[20]  R. Kacmarek,et al.  Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[21]  P. Agostoni,et al.  Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. , 1997, Circulation.

[22]  J. Connell,et al.  Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. , 1996, Journal of molecular endocrinology.

[23]  D. Hayoz,et al.  Endothelial dysfunction in chronic heart failure. Experimental and clinical studies. , 1994, Arzneimittel-Forschung.

[24]  J. E. Hansen,et al.  Principles of Exercise Testing and Interpretation , 1994 .

[25]  S. Yusuf,et al.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.

[26]  S. Yusuf,et al.  Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure , 1992, Circulation.

[27]  F. Soubrier,et al.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.

[28]  K. Kawamura,et al.  Peripheral hemodynamic effects of captopril in patients with congestive heart failure. , 1989, American heart journal.

[29]  G Borg,et al.  Subjective effort and physical abilities. , 1978, Scandinavian journal of rehabilitation medicine. Supplement.

[30]  U. Ryan,et al.  Localization of angiotensin converting enzyme (kininase II). I. Preparation of antibody-hemeoctapeptide conjugates. , 1976, Tissue & cell.

[31]  P. Hugh-Jones,et al.  Terminology for Measurements of Ventilatory Capacity , 1957, Thorax.